Scholar Rock Holding Current Ratio 2018-2018 | SRRK

Historical current ratio values for Scholar Rock Holding (SRRK) over the last 10 years.
Scholar Rock Holding Annual Current Ratio
2017 0.00
Scholar Rock Holding Quarterly Current Ratio
Q2 2018 17.49
Q4 2017 0.00
Q2 2017 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.351B $0.000B
Scholar Rock Holding Corporation is a biopharmaceutical company. It focused on the discovery and development of medicines for treatment of serious diseases. The company's product candidate includes SRK-015 and BMP6 which is in pre-clinical stage. Scholar Rock Holding Corporation is based in Cambridge, United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $126.710B 14.54
Gilead Sciences (GILD) United States $100.220B 11.12
Biogen (BIIB) United States $69.222B 14.67
Celgene (CELG) United States $65.209B 13.02
Illumina (ILMN) United States $48.535B 60.81
Vertex Pharmaceuticals (VRTX) United States $44.961B 102.29
Regeneron Pharmaceuticals (REGN) United States $39.573B 22.25
Alexion Pharmaceuticals (ALXN) United States $26.672B 20.05
BioMarin Pharmaceutical (BMRN) United States $18.317B 0.00
Incyte (INCY) United States $14.126B 474.64
Seattle Genetics (SGEN) United States $11.851B 0.00
Alnylam Pharmaceuticals (ALNY) United States $9.380B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.361B 60.17
BeiGene (BGNE) Cayman Islands $8.817B 0.00
QIAGEN (QGEN) Netherlands $8.650B 28.28
Bluebird Bio (BLUE) United States $8.470B 0.00
Sarepta Therapeutics (SRPT) United States $8.297B 0.00
Alkermes (ALKS) Ireland $6.904B 0.00
Bio-Techne Corp (TECH) United States $6.769B 45.49
Exact Sciences (EXAS) United States $6.116B 0.00
Exelixis (EXEL) United States $5.925B 19.30
Galapagos (GLPG) Belgium $5.475B 0.00
Ligand Pharmaceuticals (LGND) United States $5.257B 46.56
Ultragenyx Pharmaceutical (RARE) United States $3.838B 0.00
Immunomedics (IMMU) United States $3.760B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.601B 0.00
Horizon Pharma Public (HZNP) Ireland $3.423B 19.38
Intercept Pharmaceuticals (ICPT) United States $3.301B 0.00
Akcea Therapeutics (AKCA) United States $3.202B 0.00
China Biologic Products (CBPO) China $3.150B 20.81
Blueprint Medicines (BPMC) United States $3.124B 0.00
Array BioPharma (ARRY) United States $3.006B 0.00
Myriad Genetics (MYGN) United States $2.974B 35.58
Medicines (MDCO) United States $2.943B 0.00
Emergent Biosolutions (EBS) United States $2.882B 22.96
Ascendis Pharma (ASND) Denmark $2.824B 0.00
ARGENX SE-ADR (ARGX) Netherlands $2.814B 0.00
Amicus Therapeutics (FOLD) United States $2.633B 0.00
Halozyme Therapeutics (HALO) United States $2.517B 33.54
Global Blood Therapeutics (GBT) United States $2.415B 0.00
Spark Therapeutics (ONCE) United States $2.305B 0.00
CRISPR THERAPTC (CRSP) Switzerland $2.278B 0.00
MyoKardia (MYOK) United States $2.265B 0.00
Acceleron Pharma (XLRN) United States $2.191B 0.00
Repligen (RGEN) United States $2.168B 72.79
REGENXBIO (RGNX) United States $2.123B 33.35
Cambrex (CBM) United States $2.019B 16.19
Momenta Pharmaceuticals (MNTA) United States $2.005B 0.00
AnaptysBio (ANAB) United States $1.996B 0.00
G1 THERAPEUTICS (GTHX) United States $1.906B 0.00
Genomic Health (GHDX) United States $1.898B 105.86
Mirati Therapeutics (MRTX) United States $1.888B 0.00
Arena Pharmaceuticals (ARNA) United States $1.820B 0.00
Clovis Oncology (CLVS) United States $1.819B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.795B 0.00
ACADIA Pharmaceuticals (ACAD) United States $1.791B 0.00
Atara Biotherapeutics (ATRA) United States $1.746B 0.00
Rubius Therapeutics (RUBY) United States $1.726B 0.00
Reata Pharmaceuticals (RETA) United States $1.713B 0.00
Puma Biotechnology (PBYI) United States $1.705B 0.00
Aimmune Therapeutics (AIMT) United States $1.654B 0.00
Sangamo Therapeutics (SGMO) United States $1.652B 0.00
Allakos (ALLK) United States $1.622B 0.00
Insmed (INSM) United States $1.619B 0.00
Lion Biotechnologies (IOVA) United States $1.525B 0.00
Myovant Sciences (MYOV) United Kingdom $1.455B 0.00
Innoviva (INVA) United States $1.428B 9.16
Denali Therapeutics (DNLI) United States $1.427B 0.00
IMMURON LTD (IMRN) Australia $1.427B 0.00
Editas Medicine (EDIT) United States $1.411B 0.00
Solid Biosciences (SLDB) United States $1.383B 0.00
WAVE Life Sciences (WVE) Singapore $1.356B 0.00
Acorda Therapeutics (ACOR) United States $1.351B 28.17
UniQure (QURE) Netherlands $1.349B 0.00
Coherus BioSciences (CHRS) United States $1.316B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.299B 0.00
Alder BioPharmaceuticals (ALDR) United States $1.296B 0.00
BIOHAVEN PHARM (BHVN) United States $1.275B 0.00
Audentes Therapeutics (BOLD) United States $1.246B 0.00
Intellia Therapeutics (NTLA) United States $1.205B 0.00
Cellectis (CLLS) France $1.183B 0.00
Lexicon Pharmaceuticals (LXRX) United States $1.154B 0.00
Intra-Cellular Therapies (ITCI) United States $1.138B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.131B 2160.00
Zai Lab Unsponsored ADR (ZLAB) China $1.109B 0.00
DBV Technologies (DBVT) France $1.095B 0.00
Retrophin (RTRX) United States $1.086B 0.00
Athenex (ATNX) United States $1.081B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.073B 0.00
NeoGenomics (NEO) United States $1.033B 180.71
CytomX Therapeutics (CTMX) United States $1.014B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.014B 0.00
Apellis Pharmaceuticals (APLS) United States $1.014B 0.00
Revance Therapeutics (RVNC) United States $0.990B 0.00
AVROBIO (AVRO) United States $0.985B 0.00
Amarin (AMRN) Ireland $0.865B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.858B 0.00
Dynavax Technologies (DVAX) United States $0.833B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.794B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.785B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.782B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.773B 0.00
Kura Oncology (KURA) United States $0.752B 0.00
Heska (HSKA) United States $0.740B 63.68
InflaRx (IFRX) Germany $0.735B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.732B 0.00
Cara Therapeutics (CARA) United States $0.724B 0.00
Aptinyx (APTX) United States $0.720B 0.00
Geron (GERN) United States $0.718B 0.00
Epizyme (EPZM) United States $0.709B 0.00
ANI Pharmaceuticals (ANIP) United States $0.674B 13.38
Eidos Therapeutics (EIDX) United States $0.666B 0.00
UNITY Biotechnology (UBX) $0.658B 0.00
Viking Therapeutics (VKTX) United States $0.648B 0.00
Abeona Therapeutics (ABEO) United States $0.623B 0.00
Anika Therapeutics (ANIK) United States $0.620B 26.08
UROGEN PHARMA (URGN) Israel $0.613B 0.00
Fate Therapeutics (FATE) United States $0.607B 0.00
Prothena (PRTA) Ireland $0.606B 0.00
Sorrento Therapeutics (SRNE) United States $0.595B 0.00
AC Immune SA (ACIU) Switzerland $0.594B 0.00
Verastem (VSTM) United States $0.590B 0.00
Mesoblast (MESO) Australia $0.574B 0.00
Arcus Biosciences (RCUS) United States $0.546B 0.00
Replimune (REPL) United States $0.531B 0.00
Senesco Technologies (ELOX) United States $0.527B 0.00
Vericel (VCEL) United States $0.527B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.522B 0.00
Novavax (NVAX) United States $0.520B 0.00
Kindred Biosciences (KIN) United States $0.512B 0.00
Arbutus Biopharma (ABUS) Canada $0.510B 0.00
Five Prime Therapeutics (FPRX) United States $0.493B 0.00
Stemline Therapeutics (STML) United States $0.477B 0.00
ObsEva SA (OBSV) Switzerland $0.474B 0.00
BeyondSpring (BYSI) United States $0.462B 0.00
MiMedx (MDXG) United States $0.453B 19.43
Zymeworks (ZYME) Canada $0.453B 0.00
Unum Therapeutics (UMRX) United States $0.442B 0.00
Zealand Pharma (ZEAL) Denmark $0.431B 0.00
Aduro Biotech (ADRO) United States $0.427B 0.00
Merus (MRUS) Netherlands $0.418B 0.00
Magenta Therapeutics (MGTA) United States $0.417B 0.00
Evelo Biosciences (EVLO) United States $0.416B 0.00
Inovio Pharmaceuticals (INO) United States $0.411B 0.00
GTx (GTXI) United States $0.407B 0.00
MediciNova (MNOV) United States $0.400B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.386B 0.00
Cytokineticsorporated (CYTK) United States $0.385B 0.00
Syros Pharmaceuticals (SYRS) United States $0.384B 0.00
Albireo Pharma (ALBO) United States $0.379B 0.00
Vital Therapies (VTL) United States $0.375B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.375B 0.00
Sinovac Biotech (SVA) China $0.367B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.366B 0.00
RA PHARMCTL INC (RARX) United States $0.355B 0.00
PDL BioPharma (PDLI) United States $0.346B 4.86
Cellular Biomedicine (CBMG) United States $0.346B 0.00
Seres Therapeutics (MCRB) United States $0.331B 0.00
Adverum Biotechnologies (ADVM) United States $0.329B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.321B 0.00
BioTime (BTX) United States $0.321B 0.00
Kezar Life Sciences (KZR) United States $0.319B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.319B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.314B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.300B 0.00
Constellation Pharmaceuticals (CNST) United States $0.297B 0.00
Mersana Therapeutics (MRSN) United States $0.296B 0.00
Kala Pharmaceuticals (KALA) United States $0.293B 0.00
ResTORbio (TORC) United States $0.292B 0.00
Strongbridge Biopharma (SBBP) United States $0.292B 0.00
Selecta Biosciences (SELB) United States $0.291B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.289B 0.00
Celyad SA (CYAD) Belgium $0.287B 0.00
Athersys (ATHX) United States $0.284B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.277B 0.00
Osiris Therapeutics (OSIR) United States $0.276B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.276B 0.00
ADMA Biologics Inc (ADMA) United States $0.271B 0.00
Cohbar (CWBR) United States $0.268B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.266B 0.00
Kadmon Holdings (KDMN) United States $0.265B 0.00
ChromaDex (CDXC) United States $0.264B 0.00
Celcuity (CELC) United States $0.263B 0.00
NantKwest (NK) United States $0.257B 0.00
Axovant Sciences (AXON) United Kingdom $0.256B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.256B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.242B 0.00
MeiraGTx Holdings (MGTX) United States $0.235B 0.00
Idera Pharmaceuticals (IDRA) United States $0.231B 0.00
Clearside Biomedical (CLSD) United States $0.231B 0.00
Allena Pharmaceuticals (ALNA) United States $0.229B 0.00
Liquidia Technologies (LQDA) United States $0.224B 0.00
Kamada (KMDA) Israel $0.221B 17.19
Agenus (AGEN) United States $0.203B 0.00
Menlo Therapeutics (MNLO) United States $0.202B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.201B 0.00
Spero Therapeutics (SPRO) United States $0.199B 0.00
Enzo Biochem (ENZ) United States $0.194B 0.00
Synlogic (SYBX) United States $0.194B 0.00
Palatin Technologies (PTN) United States $0.190B 7.35
TOCAGEN INC (TOCA) United States $0.182B 0.00
Signal Genetics (MGEN) United States $0.181B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) $0.180B 0.00
Protagonist Therapeutics (PTGX) United States $0.176B 0.00
MannKind (MNKD) United States $0.173B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.173B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.171B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.170B 0.00
Cue Biopharma (CUE) United States $0.166B 0.00
Krystal Biotech (KRYS) United States $0.166B 0.00
Mustang Bio (MBIO) United States $0.162B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.162B 0.00
OVID THERAPEUTC (OVID) United States $0.161B 0.00
BioDelivery Sciences (BDSI) United States $0.158B 0.00
XBiotech (XBIT) United States $0.158B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.157B 0.00
Compugen (CGEN) Israel $0.156B 0.00
XOMA (XOMA) United States $0.156B 16.42
Pluristem Therapeutics (PSTI) Israel $0.141B 0.00
Intec Pharma (NTEC) Israel $0.140B 0.00
Cerecor (CERC) United States $0.136B 16.79
BioXcel Therapeutics (BTAI) United States $0.135B 0.00
Provention Bio (PRVB) United States $0.132B 0.00
Motif Bio Plc (MTFB) United States $0.129B 0.00
VBI Vaccines (VBIV) United States $0.127B 0.00
Monster Digital (INNT) United States $0.127B 0.00
Organovo Holdings (ONVO) United States $0.127B 0.00
Anavex Life Sciences (AVXL) United States $0.127B 0.00
Catalyst Biosciences (CBIO) United States $0.122B 0.00
Cidara Therapeutics (CDTX) United States $0.122B 0.00
Trevena (TRVN) United States $0.122B 0.00
Checkpoint Therapeutics (CKPT) United States $0.121B 0.00
Aptevo Therapeutics (APVO) United States $0.119B 0.00
Cocrystal Pharma (COCP) United States $0.114B 0.00
PSivida (EYPT) United States $0.113B 0.00
Tapimmune (TPIV) United States $0.113B 0.00
Fortress Biotech (FBIO) United States $0.109B 0.00
Pfenex (PFNX) United States $0.108B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.106B 0.00
Leap Therapeutics (LPTX) United States $0.105B 0.00
Aptose Biosciences (APTO) Canada $0.105B 0.00
NewLink Genetics (NLNK) United States $0.105B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.100B 0.00
Orgenesis (ORGS) United States $0.100B 0.00
Asterias Biotherapeutics (AST) United States $0.097B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.092B 0.00
Eleven Biotherapeutics (SESN) United States $0.091B 0.00
Alcobra (ARCT) Israel $0.086B 0.00
Ophthotech (OPHT) United States $0.086B 0.56
Proteostasis Therapeutics (PTI) United States $0.085B 0.00
OncoSec Medical (ONCS) United States $0.083B 0.00
Sophiris Bio (SPHS) United States $0.083B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.081B 0.00
Advaxis (ADXS) United States $0.079B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.079B 0.00
Oncolytics Biotech (ONCY) Canada $0.079B 0.00
ScPharmaceuticals (SCPH) United States $0.078B 0.00
Histogenics (HSGX) United States $0.078B 0.00
Applied Genetic Technologies (AGTC) United States $0.074B 0.00
Protalix BioTherapeutics (PLX) Israel $0.074B 0.00
Evogene (EVGN) Israel $0.072B 0.00
Celldex Therapeutics (CLDX) United States $0.070B 0.00
VIVUS (VVUS) United States $0.069B 0.00
Prima BioMed (IMMP) Australia $0.068B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.068B 0.00
Alimera Sciences (ALIM) United States $0.067B 0.00
Axsome Therapeutics (AXSM) United States $0.063B 0.00
Neothetics (EVFM) United States $0.061B 0.00
Novelion Therapeutics (NVLN) Canada $0.060B 0.00
Entera Bio (ENTX) Israel $0.057B 0.00
VolitionRX (VNRX) Singapore $0.057B 0.00
Eyenovia (EYEN) United States $0.056B 0.00
Vascular Biogenics (VBLT) Israel $0.052B 0.00
Curis (CRIS) United States $0.051B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.050B 0.00
Caladrius Biosciences (CLBS) United States $0.050B 0.00
Zosano Pharma (ZSAN) United States $0.049B 0.00
CorMedix Inc (CRMD) United States $0.045B 0.00
Moleculin Biotech (MBRX) United States $0.045B 0.00
Celsion (CLSN) United States $0.044B 0.00
Chiasma (CHMA) United States $0.043B 0.00
Proteon Therapeutics (PRTO) United States $0.041B 0.00
AZURRX BIOPHARM (AZRX) United States $0.041B 0.00
VTv Therapeutics (VTVT) United States $0.040B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.038B 0.00
Bellerophon Therapeutics (BLPH) United States $0.038B 0.00
GENPREX INC (GNPX) United States $0.038B 0.00
CytRx (CYTR) United States $0.038B 0.00
TRACON Pharmaceuticals (TCON) United States $0.036B 0.00
Aileron Therapeutics (ALRN) United States $0.033B 0.00
BioPharmX (BPMX) United States $0.032B 0.00
AquaBounty Technologies (AQB) United States $0.032B 0.00
AEterna Zentaris (AEZS) United States $0.031B 62.00
Benitec Biopharma (BNTC) Australia $0.029B 0.00
OvaScience (OVAS) United States $0.029B 0.00
VistaGen Therapeutics (VTGN) United States $0.029B 0.00
Vical (VICL) United States $0.028B 0.00
Oncobiologics (ONS) United States $0.027B 0.00
Edge Therapeutics (EDGE) United States $0.027B 0.00
Arsanis (ASNS) United States $0.027B 0.00
Adial Pharmaceuticals (ADIL) United States $0.025B 0.00
Cellect Biotechnology (APOP) Israel $0.025B 0.00
Cel-Sci (CVM) United States $0.024B 0.00
Soligenix (SNGX) United States $0.024B 0.00
Cleveland BioLabs (CBLI) United States $0.023B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.022B 0.00
Gemphire Therapeutics (GEMP) United States $0.022B 0.00
ATyr Pharma (LIFE) United States $0.020B 0.00
RestorGenex (DFFN) United States $0.019B 0.00
Fibrocell Science Inc (FCSC) United States $0.019B 0.00
Titan Pharmaceuticals (TTNP) United States $0.019B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.019B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.018B 0.00
Prana Biotechnology (PRAN) Australia $0.018B 0.00
AmpliPhi Biosciences (APHB) United States $0.018B 0.00
Neuralstem (CUR) United States $0.018B 0.00
Genetic Technologies (GENE) Australia $0.018B 0.00
Novogen (KZIA) Australia $0.017B 0.00
Pulmatrix (PULM) United States $0.016B 0.00
TrovaGene (TROV) United States $0.014B 0.00
Hemispherx BioPharma (HEB) United States $0.014B 0.00
Therapix Biosciences (TRPX) Israel $0.013B 6.55
Cerulean Pharma (DARE) United States $0.012B 0.00
Alliqua BioMedical (ALQA) United States $0.011B 0.00
Flex Pharma (FLKS) United States $0.011B 0.00
Synthetic Biologics (SYN) United States $0.011B 0.00
ImmunoCellular Therapeutics (IMUC) United States $0.009B 0.00
ARCA Biopharma (ABIO) United States $0.009B 0.00
Tenax Therapeutics (TENX) United States $0.009B 0.00
MYOS RENS Technology (MYOS) United States $0.008B 0.00
Galena Biopharma (SLS) United States $0.008B 0.00
IBio (IBIO) United States $0.008B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.007B 0.00
Stellar Biotechnologies (SBOT) United States $0.004B 0.00
Oragenics (OGEN) United States $0.003B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.002B 0.00
Aytu Bioscience (AYTU) United States $0.001B 0.00